Grogan D W, Cronan J E
Department of Biological Sciences, University of Cincinnati, Ohio 45221-0006, USA.
Microbiol Mol Biol Rev. 1997 Dec;61(4):429-41. doi: 10.1128/mmbr.61.4.429-441.1997.
It has been known for several decades that cyclopropane fatty acids (CFAs) occur in the phospholipids of many species of bacteria. CFAs are formed by the addition of a methylene group, derived from the methyl group of S-adenosylmethionine, across the carbon-carbon double bond of unsaturated fatty acids (UFAs). The C1 transfer does not involve free fatty acids or intermediates of phospholipid biosynthesis but, rather, mature phospholipid molecules already incorporated into membrane bilayers. Furthermore, CFAs are typically produced at the onset of the stationary phase in bacterial cultures. CFA formation can thus be considered a conditional, postsynthetic modification of bacterial membrane lipid bilayers. This modification is noteworthy in several respects. It is catalyzed by a soluble enzyme, although one of the substrates, the UFA double bond, is normally sequestered deep within the hydrophobic interior of the phospholipid bilayer. The enzyme, CFA synthase, discriminates between phospholipid vesicles containing only saturated fatty acids and those containing UFAs; it exhibits no affinity for vesicles of the former composition. These and other properties imply that topologically novel protein-lipid interactions occur in the biosynthesis of CFAs. The timing and extent of the UFA-to-CFA conversion in batch cultures and the widespread distribution of CFA synthesis among bacteria would seem to suggest an important physiological role for this phenomenon, yet its rationale remains unclear despite experimental tests of a variety of hypotheses. Manipulation of the CFA synthase of Escherichia coli by genetic methods has nevertheless provided valuable insight into the physiology of CFA formation. It has identified the CFA synthase gene as one of several rpoS-regulated genes of E. coli and has provided for the construction of strains in which proposed cellular functions of CFAs can be properly evaluated. Cloning and manipulation of the CFA synthase structural gene have also enabled this novel but extremely unstable enzyme to be purified and analyzed in molecular terms and have led to the identification of mechanistically related enzymes in clinically important bacterial pathogens.
几十年来,人们已经知道环丙烷脂肪酸(CFA)存在于许多细菌种类的磷脂中。CFA是由来自S-腺苷甲硫氨酸甲基的亚甲基加到不饱和脂肪酸(UFA)的碳-碳双键上形成的。C1转移不涉及游离脂肪酸或磷脂生物合成的中间体,而是已经整合到膜双层中的成熟磷脂分子。此外,CFA通常在细菌培养的稳定期开始时产生。因此,CFA的形成可被视为细菌膜脂质双层的一种条件性、合成后修饰。这种修饰在几个方面值得注意。它由一种可溶性酶催化,尽管其中一个底物UFA双键通常被隔离在磷脂双层疏水内部的深处。该酶CFA合酶能够区分仅含有饱和脂肪酸的磷脂囊泡和含有UFA的磷脂囊泡;它对前一种组成的囊泡没有亲和力。这些以及其他特性表明,在CFA的生物合成中发生了拓扑学上新颖的蛋白质-脂质相互作用。分批培养中UFA向CFA转化的时间和程度以及CFA合成在细菌中的广泛分布似乎表明这一现象具有重要的生理作用,然而,尽管对各种假设进行了实验测试,其原理仍不清楚。不过,通过遗传方法对大肠杆菌的CFA合酶进行操作,为深入了解CFA形成的生理学提供了有价值的见解。它已将CFA合酶基因鉴定为大肠杆菌几个受rpoS调控的基因之一,并使得能够构建出可对CFA的假定细胞功能进行适当评估的菌株。CFA合酶结构基因的克隆和操作还使得这种新颖但极其不稳定的酶能够被纯化并进行分子分析,并导致在临床上重要的细菌病原体中鉴定出机制相关的酶。